41 Einträge gefunden

1. Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients

   1. Tzschaschel, Marie
   2. Friedl, Thomas W P
   3. Schochter, Fabienne
   4. Schütze, Sabine
   5. Polasik, Arkadius
   6. Fehm, Tanja
   7. Pantel, Klaus

   2023 - Forschungsinformationssystem des UKE
2. Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer:an international pooled analysis of individual patient data from four prospective observational studies

   1. Yamamoto, Yutaka
   2. Yamashiro, Hiroyasu
   3. Schneeweiss, Andreas
   4. Müller, Volkmar
   5. Gluz, Oleg
   6. Klare, Peter
   7. Aktas, Bahriye

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial

   1. Trapp, Elisabeth K
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Schneeweiss, Andreas
   5. Mueller, Volkmar
   6. Harbeck, Nadia
   7. Lorenz, Ralf

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study

   1. Müller, Volkmar
   2. Ruhnke, Markus
   3. Hoffmann, Oliver
   4. Grafe, Andrea
   5. Tomé, Oliver
   6. Fett, Werner
   7. Bruch, Harald-Robert

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials

   1. Furlanetto, Jenny
   2. Marmé, Frederik
   3. Seiler, Sabine
   4. Thode, Christian
   5. Untch, Michael
   6. Schmatloch, Sabine
   7. Schneeweiss, Andreas

   2021 - Forschungsinformationssystem des UKE
6. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients

   1. Lux, Michael P
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Belleville, Erik
   7. Stickeler, Elmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Therapiealgorithmen für das Mammakarzinom

   1. Blohmer, Jens-Uwe
   2. Schneeweiss, Andreas
   3. Bauerfeind, I.
   4. Fehm, T
   5. Muller , Volkmar
   6. Thomssen, Christoph
   7. Witzel, Isabell

   2021 - Forschungsinformationssystem des UKE
8. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Lederer, Bianca
   4. Fontanella, Caterina
   5. Schneeweiss, Andreas
   6. Karn, Thomas
   7. Marmé, Frederik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. AGO Algorithms for the Treatment of Breast Cancer: Update 2021

    1. Schneeweiss, Andreas
    2. Fasching, Peter A
    3. Fehm, Tanja
    4. Gerber, Bernd
    5. Jackisch, Christian
    6. Loibl, Sibylle
    7. Schmidt, Marcus

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
11. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

    1. Schneeweiss, Andreas
    2. Hartkopf, Andreas D
    3. Müller, Volkmar
    4. Wöckel, Achim
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
12. Therapy Algorithms for the Diagnosis and Treatment of Patients with Early and Advanced Breast Cancer

    1. Schneeweiss, Andreas
    2. Bauerfeind, Ingo
    3. Fehm, Tanja
    4. Janni, Wolfgang
    5. Thomssen, Christoph
    6. Witzel, Isabell
    7. Wöckel, Achim

    2020 - Forschungsinformationssystem des UKE
13. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

    1. Lüftner, Diana
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Wöckel, Achim
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
14. HER2-targeted therapy influences CTC status in metastatic breast cancer

    1. Deutsch, Thomas M
    2. Riethdorf, Sabine
    3. Fremd, Carlo
    4. Feisst, Manuel
    5. Nees, Juliane
    6. Fischer, Chiara
    7. Hartkopf, Andreas D

    2020 - Forschungsinformationssystem des UKE
15. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2020 - Forschungsinformationssystem des UKE
16. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial

    1. Rüger, Alexandra Maria
    2. Schneeweiss, Andreas
    3. Seiler, Sabine
    4. Tesch, Hans
    5. van Mackelenbergh, Marion
    6. Marmé, Frederik
    7. Lübbe, Kristina

    2020 - Forschungsinformationssystem des UKE
17. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC

    1. Massa, Chiara
    2. Karn, Thomas
    3. Denkert, Carsten
    4. Schneeweiss, Andreas
    5. Hanusch, Claus
    6. Blohmer, Jens-Uwe
    7. Zahm, Dirk-Michael

    2020 - Forschungsinformationssystem des UKE
18. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

    1. Huober, Jens
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
19. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    1. Swain, Sandra M
    2. Miles, David
    3. Kim, Sung-Bae
    4. Im, Young-Hyuck
    5. Im, Seock-Ah
    6. Semiglazov, Vladimir
    7. Ciruelos, Eva

    2020 - Forschungsinformationssystem des UKE
20. Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential

    1. Arkadius, Polasik
    2. Tzschaschel, Marie
    3. Schochter, Fabienne
    4. Friedl, Thomas W. P.
    5. Rack, Brigitte
    6. Hartkopf, Andreas
    7. Fasching, Peter A

    2019 - Forschungsinformationssystem des UKE